CARREFOUR BR (CRFB3) Main Indicators
Basic Data - CRFB3
| Company | CARREFOUR BR |
| Corporate Name | ATACADÃO S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Comércio varejista e atacadista de mercadorias em geral; Carga e descarga; Correspondentes de instituições financeiras; Atividades de teleatendimento; Serviços de Alimentação entre outros |
| Share | CRFB3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 9.15 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 118.92 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Consumo não Cíclico |
| Subsector | Comércio e Distribuição |
| Segment | Alimentos |
| Participation Indexes | AGFS, IBOVESPA, IBRA, IBRX, ICO2, ICON, IGC, IGCT, IGNM, ISE, ITAG, IVBX, MLCX |
| Updated 09/19/2024 | |
Relative Prices - CRFB3
| Price/Earnings | -301.53 |
| Price/SBV | 0.98 |
| Price/Net Sales | 0.17 |
| Price/CFO | 3.52 |
| Price/FCF | 5.46 |
| Price/Total Assets | 0.21 |
| Price/EBIT | 5.42 |
| Price/Working Capital | -9.48 |
| Price/NCAV | -0.26 |
| EV/EBIT | 9.81 |
| EV/EBITDA | 6.44 |
| EV/Net Sales | 0.31 |
| EV/CFO | 6.37 |
| EV/FCF | 9.88 |
| EV/Total Assets | 0.38 |
| Company Market Cap | R$ 19.30 B |
| Enterprise Value | R$ 34.94 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 9.15 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 0.00% |
| Updated 09/19/2024 | |
Income Statement - CRFB3
| Net Revenue | R$ 112.57 B |
| Gross Result | R$ 21.04 B |
| EBIT | R$ 3.56 B |
| Depreciation and Amortization | - R$ 1.87 B |
| EBITDA | R$ 5.43 B |
| Net Profit | - R$ 64.00 M |
| Net Profit/Share | - R$ 0.03 |
| Updated 07/22/2024 | |
| Net Revenue | R$ 29.62 B |
| Gross Result | R$ 5.24 B |
| EBIT | R$ 1.36 B |
| Depreciation and Amortization | - R$ 445.00 M |
| EBITDA | R$ 1.81 B |
| Net Profit | R$ 330.00 M |
| Profit/Share | R$ 0.16 |
| Updated 07/22/2024 | |
Price and Volume Behavior - CRFB3
| Lowest Price 52 weeks | R$ 8.50 |
| Highest Price 52 weeks | R$ 13.90 |
| Variation 2024 | -23.81% |
| Variation 1 year | -4.39% |
| Variation 2 years(total) | -54.35% |
| Variation 2 years(yearly) | -32.33% |
| Variation 3 years(total) | -46.77% |
| Variation 3 years(yearly) | -18.92% |
| Variation 4 years(total) | -53.28% |
| Variation 4 years(yearly) | -17.31% |
| Variation 5 years(total) | -53.97% |
| Variation 5 years(yearly) | -14.36% |
| Average Daily Volume (3 months) | R$ 78.44 M |
| Updated 09/19/2024 | |
Returns and Margins - CRFB3
| Return on Initial Tangible Capital | 5.14% |
| Return on Initial Invested Capital | 6.71% |
| Pre-Tax Return on Initial Tangible Capital | 7.79% |
| Pre-Tax Return on Initial Invested Capital | 10.17% |
| Return on Initial Shareholder´s Equity | -0.33% |
| Return on Initial Asset | -0.07% |
| Gross Margin | 18.69% |
| Net Margin | -0.06% |
| EBIT Margin | 3.16% |
| EBITDA Margin | 4.82% |
| Initial Asset Turnover | 1.30 |
| Financial Leverage | 4.65 |
| Liabilities/Net Worth | 3.65 |
| Net Debt/EBITDA | 2.88 |
| Updated 07/22/2024 | |
Balance Sheet - CRFB3
| Cash and Cash Equivalents | R$ 8.18 B |
| Total Assets | R$ 91.27 B |
| Short-Term Debt | R$ 13.21 B |
| Long-Term Debt | R$ 10.61 B |
| Gross Debt | R$ 23.82 B |
| Net Debt | R$ 15.64 B |
| Shareholder´s Equity | R$ 19.62 B |
| Share Book Value | R$ 9.31 |
| Common Shares | 2,108,294,411 |
| Preferred Shares | 0 |
| Total | 2,108,294,411 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 2,108,294,411 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 2,108,294,411 |
| Updated 07/22/2024 | |
Cash Flow - CRFB3
| Operating Cash Flow | R$ 5.48 B |
| Cash Flow from Investments | - R$ 1.66 B |
| Financing Cash Flow | - R$ 1.67 B |
| Increase (Reduction) in Cash and Equivalents | R$ 2.15 B |
| Updated 07/22/2024 | |
| Operating Cash Flow | R$ 3.60 B |
| Cash Flow from Investments | - R$ 74.00 M |
| Financing Cash Flow | - R$ 1.44 B |
| Increase (Reduction) in Cash and Equivalents | R$ 2.09 B |
| Updated 07/22/2024 | |
Experimental - CRFB3
| CAPEX 3 months | - R$ 19.00 M |
| Free Cash Flow 3 months | R$ 3.58 B |
| CAPEX 12 months | - R$ 1.95 B |
| Free Cash Flow 12 months | R$ 3.54 B |
| Updated 07/22/2024 | |